Gates Foundation Backs LG Chem's Hexavalent Vaccine
LG Chem gets a second grant from the Bill & Melinda Gates Foundation, this time to speed up development of its hexavalent combination vaccine for infants, which it hopes can contribute significantly to global immunization efforts.
You may also be interested in...
SK Biopharmaceuticals is pushing ahead with a planned sizable IPO in South Korea in June as it focuses on successfully commercializing novel anti-epileptic drug Xcopri in the US.
South Korea authorities talk to foreign media about the country's experience and successes in dealing with the COVID-19 situation, lessons learned, preparations being made to return to everyday life and R&D activity.
Sanofi’s decision to return to originator Hanmi all rights to the novel diabetes candidate efpeglenatide, which is in global Phase III trials, has placed the South Korean pharma in a difficult spot. Unless there are some surprisingly positive data, finding a major global partner for commercialization may be tough.